We are looking at a small pilot project, 50-100 exomes (we prefer Illumina based core). Already have some exp with OtoGenetics but their SureSelect capture based option seems pricey. Anyone ? Thanks (not sure if that is the right category to ask for it but....)
Unconfigured Ad
Collapse
X
-
Originally posted by memento View PostWe are looking at a small pilot project, 50-100 exomes (we prefer Illumina based core). Already have some exp with OtoGenetics but their SureSelect capture based option seems pricey. Anyone ? Thanks (not sure if that is the right category to ask for it but....)Interrogate key biomarkers with our hybridisation-based FISH, NGS and array products for haematology, solid tumour, cytogenetics and rare disease. Learn more
Obvious disclaimer applies!
-
-
$999 exome
We do $999 at the Columbia Genome Center. That includes all reagents, Agilent SureSelect XT Human All Exon v.2 44Mb, Library preparation, 60X depth mapped coverage, 100bp Paired End reads, sequenced on Illumina HiSeq2000 instruments, 2 months data storage, QC, reads mapped to the human reference genome, single nucleotide variants and short insertions/deletions, basic functional annotation of the variants, and summary statistics. Our average turnaround was 55 days last quarter.
I can send you recommendations from PIs who use our service. We take orders from all over the world.
We will be happy to answer any questions at [email protected]
Our FAQ is here:
Last edited by ocouronne; 02-21-2012, 10:58 AM.
Comment
-
-
so can you detail the problems?maybe we can give you feedback.Originally posted by TonyBrooks View PostWe've tested a number of exome service providers and are now going to regularly use Axeq.
We were quoted <£700 per exome using Nimblegen's latest capture.
We had a number of communication problems and delays with BGI.
Comment
-
-
Yeah,U're right!BGI-Europe will handle all issues in local region.Originally posted by Geneus View PostIf he is in the UK, shouldn't your European subsidiary be addressing these issues? Or do they lack the competence to do so?
Anyway,we'll try our best to do any kinds of problems.
you know customer forever is God!
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
Comment